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Abstract The pheochromocytoma cells are a well-known model
for studying the nerve growth factor (NGF)-induced molecular
changes during the differentiation process. The involvement of
sphingomyelin (SM) was studied using the fluorescent analogue
of ceramide, i.e. N-lissamine rhodaminyl-(12-aminododecanoyl)
D-erythro-sphingosine (C12-LRh-Cer). This fluorescent analogue
is metabolically active and can be used to follow the biosynthesis
of SM in intact cells. NGF induces a 4-fold increase of
fluorescent SM content in PC12 cells, when loaded with C12-
LRh-Cer. Treatment of PC12 cells with actinomycin D or
cycloheximide completely abolishes the NGF-induced elevation
of SM. Inhibition of p140trkA receptor by AG-879 prevents
extracellular signal-regulated kinase 1/2 phosphorylation and
suppresses the increase of SM. Inhibition of protein kinase C
(PKC), protein kinase A (PKA) and phosphatidylinositol
3-kinase does not have any effect on NGF-induced C12-LRh-
SM accumulation. On the other hand, activation of PKA or PKC
with simultaneous treatment with NGF has a synergistic effect
on increase of SM content. The NGF-induced SM increase in
PC12 cells is an effect promoted by other differentiating agents
like dibutyryl cyclic AMP or fibroblast growth factor-2 but not
by a mitogenic agent like epidermal growth factor.
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1. Introduction
The involvement of sphingolipids in the regulation of cel-
lular proliferation, di¡erentiation and programmed cell death
[1] has clearly emerged during the last years [2].
Sphingomyelin (SM), an essential structural component of
plasma membrane [3], is the precursor of molecules like cer-
amide and sphingosine-1-phosphate (S1P), which resulted to
be second messengers. Formation of ceramide through the
‘SM cycle’ has been shown to have a speci¢c role in cell cycle
arrest [4], di¡erentiation [5,6] and apoptosis [7^9]. S1P, in
turn, plays an important role in neuronal growth regulation
[10,11].
Nerve growth factor (NGF) modulates survival and di¡er-
entiation of neuronal cells. The biological activity of NGF is
mediated by the interaction with its high a⁄nity p140trkA and
low a⁄nity p75 receptors [12]. Pheochromocytoma PC12 cells,
which co-express both p140trkA and p75 receptors, are a
widely used model system to study many biochemical and
biological aspects of the di¡erentiating process [13^16], inter
alia, gangliosides biosynthesis [17,18].
Recent studies have shown that NGF reduces ceramide
levels in PC12 cells through an increase of the synthesis of
S1P [11] and that the developmental increase in SM levels is
essential in neuronal maturation [19].
In the present paper, we have investigated the possibility
that the neuronal di¡erentiation process induced by NGF in
PC12 cells could be associated to an increase in SM content.
Using a £uorescent ceramide as SM precursor, we have ob-
served that NGF induces an increase of SM content in PC12
cells and that this e¡ect depends on the activation of p140trkA
receptor and extracellular signal-regulated kinase 1/2
(ERK1=2).
2. Materials and methods
2.1. Materials
NGF 2.5S, epidermal growth factor (EGF), ¢broblast growth fac-
tor-2 (FGF-2), horse serum (HS), fetal bovine serum (FBS), RPMI
1640 medium, L-glutamine, penicillin and streptomycin were obtained
from Gibco BRL (Life Technologies, Milan, Italy). Tetradecanoyl-
phorbol-13-acetate (TPA), 3,5-di-t-butyl-4-hydroxybenzylidene cyano-
thioacetamide (AG-879), chelerythrine chloride, H-89, PD-98059, LY-
294002 and N6,2P-O-dibutyryladenosine 3P :5P-cyclic monophosphate
(dbcAMP) were purchased from Biomol (Plymouth Meeting, PA,
USA). Essentially fatty acid-free human albumin, actinomycin D
and poly-L-lysine were obtained from Sigma (Sigma-Aldrich, Milan,
Italy). N-Lissamine rhodaminyl-(12-aminododecanoyl) D-erythro-
sphingosine (C12-LRh-Cer) and N-lissamine rhodaminyl-(12-amino-
dodecanoyl) sphingosyl phosphocholine (C12-LRh-SM) were synthe-
sized as previously reported [20,21]. Solvents, thin layer chromatog-
raphy (TLC) aluminum sheets silica gel 60 and LiChroprep RP-8 for
reverse phase liquid chromatography were obtained from Merck
(Merck, Darmstadt, Germany). Cycloheximide and miscellaneous re-
agents were from BDH (BDH Italia, Milan, Italy). Protein determi-
nation was carried out with Coomassie Protein Assay reagent from
Pierce (Pierce, Rockford, IL, USA) using bovine serum albumin
(BSA) as internal standard.
2.2. Cell culture
Rat pheochromocytoma PC12 cells were maintained in RPMI 1640
medium supplemented with 10% heat-inactivated HS, 5% heat-inacti-
vated FBS, 100 U/ml penicillin, 100 Wg/ml streptomycin and 4 mM
L-glutamine at 37‡C in a humid atmosphere containing 5% CO2 and
grown in 60 mm tissue dishes (Falcon, Becton Dickinson and Com-
pany, Plymouth, UK), after poly-L-lysine coating.
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2.3. Administration of sphingolipid £uorescent analogues
C12-LRh-Cer and C12-LRh-SM (5 WM) complexed with essentially
fatty acid-free human albumin [22] were administered to PC12 cells
plated in 60 mm tissue dishes, in a ¢nal volume of 2 ml RPMI 1640
medium supplemented with 1% HS and 0.5% FBS, L-glutamine and
antibiotics.
2.4. Lipid extraction and quanti¢cation
After the incubation period, the medium was removed, the cells
washed with phosphate-bu¡ered saline (PBS) and collected. Cells
were pelleted by centrifugation, resuspended in 500 Wl Milli-Q water
and 1/50 of the suspension was used for protein determination. Media
and cell lipids were separated by reverse phase liquid column chro-
matography (LiChroprep RP-8), washing the column with water and
eluting with methanol and chloroform/methanol (C/M) 6:4 (by vol-
ume). TLC separation of the eluates was carried out using the solvent
system C/M/n-buthanol/ethyl acetate/0.25% KCl 25:16:25:25:9 (by
volume). LRh £uorescent lipids were detected under UV-light and
individual bands were scraped o¡ the gel, extracted with C/M 6:4,
or C/M/water 5:5:1 (by volume) in the case of SM and the £uores-
cence recorded in a spectro£uorimeter. Identi¢cation of C12-LRh-SM
was carried out by comparing its Rf on TLC with a standard obtained
by chemical synthesis.
SM was always quanti¢ed as total SM, that is, the sum of £uores-
cent SM recovered in the culture medium and SM associated to the
cells. In pulse experiments, SM levels were expressed as nmol of total
SM normalized to protein content and to ceramide uptake (i.e. divid-
ed by the ceramide uptake value), while in pulse/chase experiments,
total SM levels were normalized only to protein content. Data were
the mean þ S.D. values from at least three separate experiments.
Endogenous SM was determined, after perchloric acid digestion, as
reported in [23,24].
2.5. Treatments
PC12 cells were treated with 50 ng/ml NGF for 1, 3 or 7 days, and
successively incubated for 24 h with C12-LRh-Cer (5 WM) in the
presence of NGF. Alternatively, PC12 cells were incubated for 8 h
with C12-LRh-Cer (5 WM) in the presence of 50 ng/ml NGF or 10 ng/
ml FGF-2 or 10 ng/ml EGF directly added into the medium at the
start of the pulse. In the experiments with cycloheximide (2 Wg/ml),
actinomycin D (3 Wg/ml), H-89 (10 WM), chelerythrine chloride (20
WM), LY-294002 (10 WM) and PD-98059 (50 WM) cells were pre-
treated with the inhibitors for 1 h and then incubated with 5 WM
C12-LRh-Cer for 8 h in the presence or absence of NGF, maintaining
the inhibitor into the culture medium. In experiments of protein ki-
nase C (PKC) downregulation, cells were pretreated for 24 h with
1 WM TPA and then incubated with 5 WM C12-LRh-Cer for 8 h in
the presence or absence of NGF, maintaining TPA into the culture
medium. In experiments of PKC upregulation, 0.05 WM TPA was
added into the medium at the start of the pulse period together
with C12-LRh-Cer. In experiments with AG-879 (100 WM), PC12 cells
were incubated with 5 WM C12-LRh-Cer for 16 h; at the last hour of
pulse period, AG-879 was added to the medium and then cells were
washed and chased for 8 h in the presence or absence of NGF, main-
taining the inhibitor into the medium.
2.6. Fluorescence measurements
All £uorescence measurements were carried out using a Jasco
FP770 spectro£uorometer. The £uorescence intensities of LRh deriv-
atives were measured in C/M 6:4 (by volume) using excitation and
emission wavelengths of 565 and 575 nm, respectively.
2.7. Detection of ERKs phosphorylation
PC12 cells were incubated in serum-free medium supplemented with
1 mg/ml BSA and 10 Wg/ml transferrin for 1 h. Cells were then treated
with 50 ng/ml NGF for 15 min alone or pretreated with 10 mM AG-
879 for 30 min and incubated for an additional 15 min in the presence
of both inhibitor and NGF. PC12 cells were washed once with PBS
containing 100 WM sodium orthovanadate, collected with 80 Wl of lysis
bu¡er (50 mM L-glycerophosphate, 1.5 mM EGTA pH 8.5, 2 mM
orthovanadate, 1 mM dithiothreitol, 5 Wg/ml leupeptin, 1 WM benza-
mide, 1% Triton X-100, 2 mM sodium pyrophosphate, 100 U/ml
Trasilol) and centrifuged (12 000Ug, 10 min, 4‡C). Samples (30 Wg
of cell protein per lane) were run on 10% sodium dodecyl sulfate^
polyacrylamide gel electrophoresis gels, and the proteins were trans-
ferred to a transfer membrane (NEF-1002 PolyScreen, Nen, Boston,
MA, USA). The membrane was blocked in Tris-bu¡ered saline con-
taining 0.1% Tween-20 and 5% powdered skimmed milk before being
probed with an antibody directed against the dual phosphorylated
form of ERK (Biolabs, Beverly, MA, USA) and further incubated
with a horseradish peroxidase-conjugated secondary antibody (Sigma,
Milan, Italy). Phospho-ERK was detected using chemioluminescence
(ECL, Pierce, Rockford, IL, USA).
3. Results
3.1. NGF increases SM levels in PC12 cells
To investigate the e¡ect of NGF on SM content in PC12
cells during neuronal di¡erentiation, the capacity of PC12
cells to transform an exogenously added £uorescent analogue
of ceramide (C12-LRh-Cer) into the corresponding £uorescent
SM (C12-LRh-SM) was evaluated.
PC12 cells were cultured in the presence of 50 ng/ml NGF
up to 7 days and pulsed with 5 WM C12-LRh-Cer for 24 h at
di¡erent time points of NGF treatment. At the end of the
24 h pulse periods, incorporation of the £uorescent precursor
into SM was evaluated. As shown in Table 1, NGF-treated
cells showed a 2^4-fold increase in C12-LRh-SM content
compared to untreated control cells at all the time points
investigated. These data indicate that NGF caused a signi¢-
cant increase of the conversion of C12-LRh-Cer into SM dur-
ing all the period of morphogenic di¡erentiation induced by
the growth factor. It must be pointed out that the pretreat-
ment with NGF for di¡erent periods of time did not signi¢-
cantly modify the amount of C12-LRh-Cer cell-internalized
during the 24 h pulse (data not shown).
To assess the kinetics of SM accumulation in NGF-treated
versus control PC12 cells, cultures were incubated with the
growth factor or vehicle in the presence of C12-LRh-Cer.
At di¡erent time points from the beginning of the treatment,
incorporation of the £uorescent precursor into SM was eval-
uated. As shown in Fig. 1, cumulative C12-LRh-SM content
sharply increased 4^8 h after the beginning of NGF treat-
ment, reaching a plateau at 24 h. In contrast, C12-LRh-SM
accumulated at a much slower rate in control cells all
throughout the experimental period.
The e¡ect of NGF on C12-LRh-SM accumulation was
dose-dependent, maximum stimulation being observed at
50^150 ng/ml of the growth factor (data not shown).
The above data indicate that NGF increases the conversion
of exogenously added C12-LRh-Cer into SM.
Fig. 1. Kinetics of C12-LRh-SM accumulation in PC12 cells. PC12
cells were pulsed with C12-LRh-Cer (5 WM) for 1^48 h, in the pres-
ence (open circles) or absence (closed circles) of 50 ng/ml NGF. To-
tal C12-LRh-SM is expressed as described in Section 2.
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In order to be sure that the observed increases were not due
to an artifact arising from the use of a £uorescent analogue of
ceramide as precursor for SM, we investigated the e¡ect of
NGF on endogenous SM content in PC12 cells. Therefore,
PC12 cells were incubated in the presence of NGF for di¡er-
ent times and the SM detected. As shown in Fig. 2, the en-
dogenous SM content signi¢cantly increased over time.
3.2. Upregulation of SM content by NGF depends on
transcriptional/translational events
PC12 cells pretreated for 1 h with the transcriptional inhib-
itor actinomycin D (3 Wg/ml) or the translational inhibitor
cycloheximide (2 Wg/ml) were incubated for 8 h with 5 WM
C12-LRh-Cer in the presence or absence of NGF. The addi-
tion of actinomycin D or cycloheximide resulted in a complete
abolishment of the NGF e¡ect on C12-LRh-SM accumulation
(Fig. 3), indicating that the growth factor increases SM levels
via mRNA and protein synthesis. It must be pointed out that
actinomycin D and cycloheximide pretreatment did not a¡ect
the capacity of NGF to cause activation of ERK1=2 in PC12
cells (data not shown), thus indicating that the inhibition of
mRNA or protein synthesis did not interfere with the early
intracellular signaling activated by the growth factor.
3.3. Degradation of SM is slowed down by NGF
Degradation of SM to the corresponding ceramide was as-
sessed in PC12 cells in the presence or absence of NGF. Cells
were pulsed for 3 h in the presence of 5 WM C12-LRh-SM and
then chased for 4 h in fresh medium with or without 50 ng/ml
NGF. Cells treated with the growth factor showed a £uores-
cent ceramide content (0.017 nmol/mg protein) of which was
50% lower than the control (0.034 nmol/mg protein).
3.4. Increase of SM accumulation by NGF depends on the
activity of p140trkA receptor
Since NGF is known to exert most of its activities in PC12
cells by binding to the p140trkA receptor [12], we decided to
evaluate the e¡ect of the p140trkA inhibitor AG-879 [25] on
NGF-mediated C12-LRh-SM accumulation. As shown in Fig.
4, AG-879 completely abolished ERK1=2 phosphorylation and
the increase of C12-LRh-SM levels induced by the growth
factor in PC12 cells, indicating that the tyrosine kinase activ-
ity of p140trkA receptor is essential for this e¡ect.
3.5. Increase of SM accumulation by NGF requires ERK1=2
activation
Activation of p140trkA receptor by NGF triggers various
intracellular signaling pathways, including PKC-, phosphati-
dylinositol 3-kinase (PI3-K)- and ERK1=2-dependent path-
ways [26]. In order to identify the signal transduction pathway
involved in NGF-mediated upregulation of SM content, PC12
cells were pretreated for 1 h with the protein kinase A (PKA)
inhibitor H-89 [27], the PKC inhibitor chelerythrine chloride
[28], the PI3-K inhibitor LY-294002 [29] or the mitogen-acti-
vated protein kinase kinase 1 (MEK1) inhibitor PD-98059
[30]. Then, cells were pulsed for 8 h with 5 WM C12-LRh-
Table 1
E¡ects of NGF on SM levels
Treatment C12-LRh-SM level
nmol/mg/24 h uptake þ S.D. Fold increase
Control 0.0324 þ 0.007 1.00
NGF pretreatment (days)
0 0.0682 þ 0.010 2.10
1 0.1100 þ 0.020 3.40
3 0.1340 þ 0.022 4.14
7 0.0929 þ 0.025 2.90
PC12 cells were pretreated with NGF for 0, 1, 3 or 7 days and
than incubated with 5 WM C12-LRh-Cer for a further 24 h in the
presence of the growth factor. Control cultures were treated for an
additional 24 h with C12-LRh-Cer only. Total C12-LRh-SM values
are expressed as described in Section 2. In the last column, C12-
LRh-SM levels are expressed as fold increase over control values.
Fig. 2. E¡ect of NGF on endogenous SM levels. PC12 cells were
treated for 4, 8 and 24 h with 50 ng/ml NGF or cultured for the
same period in the absence of the growth factor (control value),
and the SM content was determined as reported in Section 2 and
expressed as nmol per 10 million cells.
Fig. 3. E¡ect of transcriptional and translational inhibitors on C12-
LRh-SM levels increased by NGF. 1 h preincubation with 2 Wg/ml
cycloheximide or 3 Wg/ml actinomycin D completely abolished the
increase of SM levels induced by 8 h treatment with 50 ng/ml NGF.
Total SM values (see Section 2) are expressed as fold increase over
the control. 1 (control value) corresponds to 0.038 þ 0.006 nmol/mg/
8 h uptake.
Table 2
Synergistic e¡ect on SM accumulation between NGF and PKA or
PKC activation
Treatment NGF C12-LRh-SM
(fold increase þ S.D.)
3 3 1.00
+ 3.91 þ 0.45
10 ng/ml dbcAMP 3 1.73 þ 0.17
+ 9.75 þ 0.51
0.05 WM TPA for 5 h 3 1.02 þ 0.11
+ 8.75 þ 0.62
PC12 cells were incubated with 5 WM C12-LRh-Cer for 5 h in the
absence or presence of 50 ng/ml NGF and in the presence of 10 ng/
ml dbcAMP or 0.05 WM TPA, respectively. Total SM values (see
Section 2) are expressed as fold increase over the control. 1.00 (con-
trol value) corresponds to 0.038 þ 0.006 nmol/mg/8 h uptake.
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Cer in the absence or presence of NGF, being each speci¢c
inhibitor added. As shown in Fig. 5, only PD-98059 caused a
signi¢cant reduction of the synthesis of C12-LRh-SM induced
by NGF, whereas all the other inhibitors were ine¡ective. The
lack of a role of PKC in NGF-induced C12-LRh-SM accu-
mulation was con¢rmed in PC12 cells in which PKC has been
downregulated by 1 WM TPA pretreatment (Fig. 5). Taken
together, these data indicate that activation of the ERK1=2
signaling pathway by p140trkA is responsible for the increase
of C12-LRh-SM synthesis induced by NGF in PC12 cells.
3.6. Activation of PKA or PKC with simultaneous treatment
with NGF further enhances SM content in PC12 cells
Activation of PKA with dbcAMP, a permeable analogue of
cAMP, caused a signi¢cant increase of SM levels in PC12 cells
(Table 2). However, the concomitant presence of NGF had a
synergistic e¡ect on SM content which was more than 2-fold
greater than in cells treated with NGF alone (Table 2).
Moreover, even though 0.05 WM TPA over 5 h did not
a¡ect the basal levels of SM, the phorbol ester caused a
2-fold increase of the SM accumulation induced by NGF
alone (Table 2). Thus, activation of PKA or PKC strongly
potentiates the e¡ect of NGF on SM accumulation in PC12
cells.
3.7. Other di¡erentiation factors cause SM accumulation in
PC12 cells
The ability of NGF and dbcAMP [31] of increasing SM
content in PC12 cells was compared with that of the FGF-
2, another di¡erentiating agent [32], and that of the EGF, a
mitogenic agent in PC12 cells [33].
As shown in Table 3, administration of either the di¡er-
entiation factors NGF, FGF-2 and dbcAMP but not the mi-
togenic growth factor EGF induced a signi¢cant increase in
SM content in PC12 cells.
4. Discussion
The present study provides evidence that NGF stimulates
the accumulation of SM in PC12 cells. This result derives both
from evidences obtained following the incorporation into SM
of a £uorescent analogue of ceramide (i.e. C12-LRh-Cer) and
from determination of endogenous SM, as well.
The highest fold increase obtained for £uorescent SM prob-
ably re£ects the fact that the C12-LRh-SM does not accumu-
late into the cell because the polarity of the £uorochrome
determines its release into the medium [22], and PC12 cells
Fig. 4. E¡ect of tyrosine kinase inhibitor AG-879 on increase of
C12-LRh-SM levels induced by NGF. PC12 cells were pulsed for
16 h with 5 WM C12-LRh-Cer, washed and treated for 8 h in the
presence of AG-879 and/or NGF. AG-879 completely abolished the
e¡ect of NGF on SM levels. Total SM values are expressed as fold
increase over the control (see Section 2). 1 (control value) corre-
sponds to 0.063 þ 0.005 nmol/mg. Inset: blocking of NGF-activated
ERKs phosphorylation in PC12 cells by AG-879 inhibitor. PC12
cells were incubated in serum-free medium supplemented with 1 mg/
ml BSA and 10 Wg/ml transferrin for 1 h (lane 1). Cells were then
treated with 50 ng/ml NGF for 15 min alone (lane 2) or pretreated
with 10 mM AG-879 for 30 min and incubated for an additional
15 min in the presence of both inhibitor and NGF (lane 3). ERKs
phosphorylation was detected as described in Section 2.
Fig. 5. Identi¢cation of the signal transduction pathway involved in NGF-mediated upregulation of SM content. PC12 cells were incubated for
8 h in the absence or in presence of 50 ng/ml NGF and in the presence of 50 WM PD-98059 (MEK1 inhibitor), 10 WM H-89 (PKA inhibitor),
20 WM chelerythrine chloride (PKC inhibitor), 1 WM TPA (for downregulating PKC activity) and 10 WM LY-294002 (PI3-K inhibitor), respec-
tively. Total SM values (see Section 2) are expressed as fold increase over the control. 1 (control value) corresponds to 0.038 þ 0.006 nmol/mg/
8 h uptake.
Table 3
E¡ect of di¡erentiating and mitogenic agents on increasing of SM
content
Treatment (8 h pulse) C12-LRh-SM levels (fold increase þ S.D.)
Control 1.00
NGF 3.91 þ 0.45
FGF-2 1.85 þ 0.19
dbcAMP 1.73 þ 0.17
EGF 1.08 þ 0.08
PC12 cells were incubated with 5 WM C12-LRh-Cer for 8 h in the
absence (control) or presence of 50 ng/ml NGF, 10 ng/ml FGF-2,
1 mM dbcAMP and 10 ng/ml EGF, respectively. Total SM values
(see Section 2) are expressed as fold increase over the control. 1.00
(control value) corresponds to 0.038 þ 0.006 nmol/mg/8 h uptake.
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are continuously stimulated to synthesize SM. The use of the
£uorescent tool has revealed to be more practical and has
been preferred to the classical method for SM determina-
tion.
Inhibition of transcription or inhibition of protein synthesis
completely abolished the e¡ect of NGF on SM accumulation.
Thus, a process of protein neosynthesis is essential for NGF
modulation of SM levels. Therefore, an increase of the en-
zyme SM synthase and/or the synthesis of an activator protein
can be hypothesized. Moreover, the prolonged half life of SM
in the presence of NGF, as resulted from our experiments in
which PC12 cells were loaded with C12-LRh-SM, can parti-
ally contribute to the observed increase of SM content during
di¡erentiation in PC12 cells.
The role of the activation of kinases ERK1 and ERK2 via
p140trkA receptor in the di¡erentiation process induced by
NGF has been clearly established [34]. We have demonstrated
that AG-879, an inhibitor of NGF p140trkA receptor, and PD-
98059, a speci¢c inhibitor of MEK1 [30], prevented accumu-
lation of SM by NGF. This indicates that activation of the
Ras cascade by p140trkA receptor engagement is required for
the observed biological e¡ect of NGF.
The use of PKA, PKC or PI3-K by H-89, chelerythrine
chloride or LY-294002, respectively, did not in£uence the
SM elevation promoted by NGF. This means that NGF
does not in£uence the SM elevation promoted by NGF.
This means that NGF does not primarily use these signaling
components to induce SM synthesis. The activation of PKC
by TPA did not induce any increase in SM levels in PC12
cells ; however, if the cells are treated with NGF, concomitant
stimulation of PKC by TPA results in a striking synergistic
e¡ect. A similar situation was obtained when PKA was acti-
vated by dbcAMP. NGF and dbcAMP are known to induce
di¡erentiation in PC12 cells and have additive and synergistic
e¡ects on neuritogenesis [32]. As shown in Table 2, the con-
current presence of dbcAMP and NGF induced a greater
increase in SM synthesis than did the individual agents.
DbcAMP added alone to control undi¡erentiated cells had
a limited but clear e¡ect on increasing SM content. Thus,
the cellular mechanisms involved in the SM increase by the
two di¡erentiating agents does not appear to be the same,
as reported in the case of dopamine increase in PC12 cells
[35].
Besides NGF, other di¡erentiating factors in PC12 cells,
like FGF-2 and dbcAMP, but not the mitogenic factor
EGF, induce an accumulation of SM. These data are in keep-
ing with the hypothesis that increase in SM could play an
important role in neuronal di¡erentiation [19].
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